These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36782326)

  • 1. Interstitial lung abnormalities in a large clinical lung cancer screening cohort: association with mortality and ILD diagnosis.
    Patel AS; Miller E; Regis SM; Hunninghake GM; Price LL; Gawlik M; McKee AB; Rieger-Christ KM; Pinto-Plata V; Liesching TN; Wald C; Hashim J; McKee BJ; Gazourian L
    Respir Res; 2023 Feb; 24(1):49. PubMed ID: 36782326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated CT quantification of interstitial lung abnormality and interstitial lung disease according to the Fleischner Society in patients with resectable lung cancer: prognostic significance.
    Ahn Y; Lee SM; Choi S; Lee JS; Choe J; Do KH; Seo JB
    Eur Radiol; 2023 Nov; 33(11):8251-8262. PubMed ID: 37266656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis.
    Kawano-Dourado L; Doyle TJ; Bonfiglioli K; Sawamura MVY; Nakagawa RH; Arimura FE; Lee HJ; Rangel DAS; Bueno C; Carvalho CRR; Sabbag ML; Molina C; Rosas IO; Kairalla RA
    Chest; 2020 Oct; 158(4):1546-1554. PubMed ID: 32428513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased respiratory morbidity in individuals with interstitial lung abnormalities.
    Hoyer N; Thomsen LH; Wille MMW; Wilcke T; Dirksen A; Pedersen JH; Saghir Z; Ashraf H; Shaker SB
    BMC Pulm Med; 2020 Mar; 20(1):67. PubMed ID: 32188453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interstitial lung abnormalities in the Queensland Lung Cancer Screening Study: prevalence and progression over 2 years of surveillance.
    Mackintosh JA; Marshall HM; Slaughter R; Reddy T; Yang IA; Bowman RV; Fong KM
    Intern Med J; 2019 Jul; 49(7):843-849. PubMed ID: 30350396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung Disease.
    Salisbury ML; Hewlett JC; Ding G; Markin CR; Douglas K; Mason W; Guttentag A; Phillips JA; Cogan JD; Reiss S; Mitchell DB; Wu P; Young LR; Lancaster LH; Loyd JE; Humphries SM; Lynch DA; Kropski JA; Blackwell TS
    Am J Respir Crit Care Med; 2020 May; 201(10):1230-1239. PubMed ID: 32011901
    [No Abstract]   [Full Text] [Related]  

  • 7. Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer.
    Nakanishi Y; Masuda T; Yamaguchi K; Sakamoto S; Horimasu Y; Nakashima T; Miyamoto S; Tsutani Y; Iwamoto H; Fujitaka K; Miyata Y; Hamada H; Okada M; Hattori N
    Respir Investig; 2019 Sep; 57(5):451-459. PubMed ID: 31248832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deleterious impact of trivial to severe interstitial pneumonia and emphysema on mortality and acute exacerbation of interstitial pneumonia in patients with lung cancer: a retrospective cohort study.
    Tomishima Y; Kitamura A; Imai R; Ohde S
    BMC Pulm Med; 2024 Jun; 24(1):290. PubMed ID: 38909185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, Risk Factors, and Outcomes of Adult Interstitial Lung Abnormalities: A Systematic Review and Meta-Analysis.
    Grant-Orser A; Min B; Elmrayed S; Podolanczuk AJ; Johannson KA
    Am J Respir Crit Care Med; 2023 Sep; 208(6):695-708. PubMed ID: 37534937
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence and prognostic meaning of interstitial lung abnormalities in remote CT scans of patients with interstitial lung disease treated with antifibrotic therapy.
    García Mullor MM; Arenas-Jiménez JJ; Ureña Vacas A; Gayá García-Manso I; Pérez Pérez JL; Serra Serra N; García Sevila R
    Radiologia (Engl Ed); 2024 Apr; 66 Suppl 1():S10-S23. PubMed ID: 38642956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Long-term Outcomes of CT Interstitial Lung Abnormalities in a Health Screening Cohort.
    Lee JE; Chae KJ; Suh YJ; Jeong WG; Lee T; Kim YH; Jin GY; Jeong YJ
    Radiology; 2023 Feb; 306(2):e221172. PubMed ID: 36219115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnoses and treatments for participants with interstitial lung abnormalities detected in the Yorkshire Lung Screening Trial.
    Upperton S; Beirne P; Bhartia B; Boland A; Bradley C; Crosbie PAJ; Darby M; Eckert C; Gabe R; Hancock N; Kennedy MPT; Lindop J; Rogerson S; Shinkins B; Simmonds I; Sutherland TJT; Callister MEJ
    BMJ Open Respir Res; 2023 Aug; 10(1):. PubMed ID: 37612098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative.
    Hunninghake GM; Goldin JG; Kadoch MA; Kropski JA; Rosas IO; Wells AU; Yadav R; Lazarus HM; Abtin FG; Corte TJ; de Andrade JA; Johannson KA; Kolb MR; Lynch DA; Oldham JM; Spagnolo P; Strek ME; Tomassetti S; Washko GR; White ES;
    Chest; 2022 Feb; 161(2):470-482. PubMed ID: 34197782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung cancer screening provides an opportunity for early diagnosis and treatment of interstitial lung disease.
    Hewitt RJ; Bartlett EC; Ganatra R; Butt H; Kouranos V; Chua F; Kokosi M; Molyneaux PL; Desai SR; Wells AU; Jenkins RG; Renzoni EA; Kemp SV; Devaraj A; George PM
    Thorax; 2022 Nov; 77(11):1149-1151. PubMed ID: 35940878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suspected Interstitial Lung Disease in COPDGene Study.
    Rose JA; Menon AA; Hino T; Hata A; Nishino M; Lynch DA; Rosas IO; El-Chemaly S; Raby BA; Ash SY; Choi B; Washko GR; Silverman EK; Cho MH; Hatabu H; Putman RK; Hunninghake GM
    Am J Respir Crit Care Med; 2023 Jan; 207(1):60-68. PubMed ID: 35930450
    [No Abstract]   [Full Text] [Related]  

  • 16. Association between interstitial lung abnormality and mortality in patients with esophageal cancer.
    Hata A; Yanagawa M; Miyata T; Hiraoka Y; Shirae M; Ninomiya K; Doi S; Yamagata K; Yoshida Y; Kikuchi N; Ogawa R; Hatabu H; Tomiyama N
    Jpn J Radiol; 2024 Aug; 42(8):841-851. PubMed ID: 38658500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate.
    Jin GY; Lynch D; Chawla A; Garg K; Tammemagi MC; Sahin H; Misumi S; Kwon KS
    Radiology; 2013 Aug; 268(2):563-71. PubMed ID: 23513242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An observational cohort study of interstitial lung abnormalities (ILAs) in a large Japanese health screening population (Kumamoto ILA study in Japan: KILA-J).
    Ichikado K; Ichiyasu H; Iyonaga K; Kawamura K; Higashi N; Johkoh T; Fujimoto K; Morinaga J; Yoshida M; Mitsuzaki K; Suga M; Tanabe N; Handa T; Hirai T; Sakagami T
    BMC Pulm Med; 2023 Jun; 23(1):199. PubMed ID: 37291485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development, Progression, and Mortality of Suspected Interstitial Lung Disease in COPDGene.
    Rose JA; Tukpah AC; Cutting C; Wada N; Nishino M; Moll M; Kalra S; Choi B; Lynch DA; Raby BA; Rosas IO; San José Estépar R; Washko GR; Silverman EK; Cho MH; Hatabu H; Putman RK; Hunninghake GM
    Am J Respir Crit Care Med; 2024 Dec; 210(12):1453-1460. PubMed ID: 39133466
    [No Abstract]   [Full Text] [Related]  

  • 20. Interstitial Lung Abnormalities at CT in the Korean National Lung Cancer Screening Program: Prevalence and Deep Learning-based Texture Analysis.
    Chae KJ; Lim S; Seo JB; Hwang HJ; Choi H; Lynch D; Jin GY
    Radiology; 2023 May; 307(4):e222828. PubMed ID: 37097142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.